Notably, malignant cells possess an inherent advantage in the competition for glucose, as NSUN2-mediated m5C modifications of GLUT1 enhance this advantage by facilitating efficient glucose acquisition, thereby establishing a positive feedback loop that further enables tumor cells to outcompete surrounding cells for available resources. This evidence concerns the gene NSUN2 and neoplasm.